PROGNOSIS VoIP Monitor Entitlement

Integrated Research is pleased to offer an entitlement for PROGNOSIS VoIP Monitor to all Avaya Communication Manager customers. The entitlement enables all Avaya Communication Manager customers to monitor the health of a single PBX and voice quality of the first 250 phones from a single PROGNOSIS installation. 

PROGNOSIS VoIP Monitor Entitlement is ideal for smaller organizations or organizations transitioning to IP telephony.

Get your organization's entitlement license now.

PROGNOSIS VoIP Monitor Plus

PROGNOSIS VoIP Monitor Plus extends the entitlement to provide complete voice quality visibility and deeper device insight across all PBXs.

Voice quality information is available for every phone, gateway and board - ensuring visibility of every second of every call.  Detailed configuration, status and performance information is available for all phones, boards, trunks, port networks, gateways and route patterns - enabling one-click root-cause troubleshooting.  Monitor up to 10 Avaya Communication Manager PBXs, and their LSPs, from a single PROGNOSIS server - providing seamless visibility and consolidated perspectives.

PROGNOSIS VoIP Monitor Plus is ideal for organizations with 1 PBX wanting complete insight, or organizations wanting visibility across all their PBXs and IP Trunks.

The first 250 phones are available as part of the entitlement, additional licenses must be purchased to cover all additional phones. For more information, including pricing and a license calculator, see How To Buy.

Unleashed Trial

If your organization is interested in PROGNOSIS VoIP Monitor Plus you can get started today with an Unleashed Trial. The Unleashed Trial grants full access to PROGNOSIS VoIP Monitor for 30 days - all features, maximum phones, maximum PBXs.

Start your organization's trial today, by downloading a 30-day unleashed trial.

Please note that the Unleashed Trial is a one-time offer per organization. If your organization has already completed a trial, please contact your Reseller or Integrated Research to discuss trial requirements or purchasing options.